I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Hassanein, T
353
results:
Search for persons
X
Format
Online (353)
Mediatypes
Articles (Online) (243)
Bookchapter (Online) (5)
OpenAccess-fulltext (105)
Languages
english (316)
more...
french (1)
russian (1)
portuguese (1)
less...
Sorted by: Relevance
Sorted by: Year
?
1
Is the presence of fat and fibrosis a higher mortality risk..:
Hefner, A.M.
;
Hassanein, T.
Journal of Hepatology. 68 (2018) - p. S367 , 2018
Link:
https://doi.org/10.1016/..
?
2
Is treatment of hepatitis C with controlled generic direct ..:
Soliman, G.
;
Negm, M.S.
;
Elzalabany, M.
...
Journal of Hepatology. 68 (2018) - p. S276 , 2018
Link:
https://doi.org/10.1016/..
?
3
Opal, but not MARS improves patients albumin binding functi..:
Kortgen, A.
;
Stange, J.
;
Sponholz, C.
...
Journal of Hepatology. 68 (2018) - p. S591 , 2018
Link:
https://doi.org/10.1016/..
?
4
Pharmacokinetics and pharmacodynamics of seladelpar, a pote..:
Boudes, P.
;
Michael, G.
;
Bowlus, C.
...
Journal of Hepatology. 68 (2018) - p. S235 , 2018
Link:
https://doi.org/10.1016/..
?
5
Treatment efficacy and safety of seladelpar, a selective pe..:
Hirschfield, G.
;
Boudes, P.
;
Bowlus, C.
...
Journal of Hepatology. 68 (2018) - p. S105-S106 , 2018
Link:
https://doi.org/10.1016/..
?
6
The anti-fibrotic agent, tipelukast (MN-001) reduces serum ..:
Matsuda, K.
;
Gutierrez, J.
;
Hassanein, T.
.
Journal of Hepatology. 68 (2018) - p. S586 , 2018
Link:
https://doi.org/10.1016/..
?
7
Mass screening for hepatitis B and C in South Upper Egypt: ..:
Soliman, G.
;
Elzalabany, M.
;
Hassanein, T.
.
Journal of Hepatology. 68 (2018) - p. S180-S181 , 2018
Link:
https://doi.org/10.1016/..
?
8
Integrated analysis of controlled clinical trials evaluatin..:
Nguyen, M.H.
;
Chuang, W.-L.
;
Hassanein, T.
...
Journal of Hepatology. 66 (2017) 1 - p. S723 , 2017
Link:
https://doi.org/10.1016/..
?
9
EXPEDITION-I: efficacy and safety of glecaprevir/pibrentasv..:
Forns, X.
;
Lee, S.
;
Valdes, J.
...
Journal of Hepatology. 66 (2017) 1 - p. S3-S4 , 2017
Link:
https://doi.org/10.1016/..
?
10
High SVR Rates in Patients with Genotype 4 Chronic Hepatiti..:
Asselah, T.
;
Hezode, C.
;
Qaqish, R.B.
...
Journal of Hepatology. 64 (2016) 2 - p. S827 , 2016
Link:
https://doi.org/10.1016/..
?
11
A More Intensive Regimen of Albumin Dyalisis Improves Survi..:
Samaniego, L.I.
;
Olmedo, C.
;
Pavesi, M.
...
Journal of Hepatology. 64 (2016) 2 - p. S272-S273 , 2016
Link:
https://doi.org/10.1016/..
?
12
100% SVR4 and Favorable Safety of ABT-493 + ABT-530 Adminis..:
Gane, E.
;
Lalezari, J.
;
Asatryan, A.
...
Journal of Hepatology. 64 (2016) 2 - p. S758 , 2016
Link:
https://doi.org/10.1016/..
?
13
High SVR Rates with the Combination of ABT-493 + ABT-530 fo..:
Poordad, F.
;
Felizarta, F.
;
Wang, S.
...
Journal of Hepatology. 64 (2016) 2 - p. S768 , 2016
Link:
https://doi.org/10.1016/..
?
14
High Efficacy and Favorable Safety of ABT-493 and ABT-530 C..:
Gane, E.
;
Poordad, F.
;
Asatryan, A.
...
Journal of Hepatology. 64 (2016) 2 - p. S757 , 2016
Link:
https://doi.org/10.1016/..
?
15
LP02 : C-surfer: grazoprevir plus elbasvir in treatment-nai..:
Roth, D.
;
Nelson, D.
;
Bruchfeld, A.
...
Journal of Hepatology. 62 (2015) - p. S263-S264 , 2015
Link:
https://doi.org/10.1016/..
1-15